ANNOUNCEMENT ON REMDESIVIR
For treatment of suspected or laboratory confirmed corona virus disease 2019 (COVID-19) in adults and children hospitalized with moderate to severe disease.
Mylan gets DCGI nod for remdesivir in India, to Launch at Rs. 4,800 per vial
Mylan launches generic version of Remdesivir in India for Covid-19 patients